Immunohistochemical study as a tool in differential diagnosis of pediatric malignant rhabdoid tumor

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 2, 2010, Pages 150-158

  MacHado, Isidro ^a   Noguera, Rosa ^a   Santonja, Nuria ^a   Donat, Joaquín ^b   Fernandez Delgado, Rafael ^b   Acevedo, Agustín ^c   Baragaño, Marta ^c   Navarro, Samuel ^a,c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b University Hospital   (United States)

^c HOSPITAL QUIRÓN   (Spain)

Author keywords

INI1; Malignant rhabdoid tumor; Pediatric tumors

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CARBOPLATIN; CD99 ANTIGEN; CISPLATIN; CYTOKERATIN; DOXORUBICIN; ETOPOSIDE; GAMMA GLUTAMYLTRANSFERASE; IFOSFAMIDE; RNA BINDING PROTEIN EWS; VIMENTIN; VINCRISTINE;

ABDOMINAL BLEEDING; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORPHOLOGY; CASE REPORT; CAUSE OF DEATH; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFERENTIAL DIAGNOSIS; DNA PROBE; EWING SARCOMA; EWSR1 GENE; FEMALE; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENETIC MARKER; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; INTRACRANIAL HYPERTENSION; LEUKOCYTOSIS; LIVER PARENCHYMA; LIVER SURGERY; LIVER TUMOR; LUNG NODULE; MALIGNANT HEPATIC RHABDOID TUMOR; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT SOFT TISSUE RHABDOID TUMOR; MULTIPLE CYCLE TREATMENT; MYCN GENE; NEEDLE BIOPSY; NEPHROBLASTOMA; NEUROBLASTOMA; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOID TUMOR; SKIN BIOPSY; SKIN NODULE; SMALL CELL SARCOMA; TREATMENT RESPONSE; TUMOR GENE; TUMOR GROWTH;

ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL ADHESION MOLECULES; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; KERATINS; LIVER NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; NUCLEAR PROTEINS; ONCOGENE PROTEINS; RHABDOID TUMOR; RNA-BINDING PROTEIN EWS; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; VIMENTIN;

EID: 77649123309     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181b91a51     Document Type: Article

References (56)

1. Alaggio R, Boldrini R, Venosa BD, et al. Pediatric extra-renal rhabdoid tumors with unusual morphology: A diagnostic pitfall for small biopsies. Pathol Res Pract. 2009;205:451-457.
2. Blatt J, Russo P, Taylor S. Extrarenal rhabdoid sarcoma. Med Pediatr Oncol. 1986;14:221-226.
3. Bourdeaut F, Freneaux P, Thuille B, et al. Extra-renal non-cerebral rhabdoid tumours. Pediatr Blood Cancer. 2008;51:363-368.
4. Kohashi K, Oda Y, Yamamoto H, et al. Highly aggressive behavior of malignant rhabdoid tumor: A special reference to SMARCB1/ INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR. J Cancer Res Clin Oncol. 2007;133: 817-824.
5. Oda Y, Tsuneyoshi M. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int. 2006;56:287-295.
6. Reinhard H, Reinert J, Beier R, et al. Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. Oncol Rep. 2008;19:819-823.
7. Weeks DA, Beckwith JB, Mierau GW. Rhabdoid tumor. An entity or a phenotype? Arch Pathol Lab Med. 1989;113:113-114.
8. Weeks DA, Beckwith JB, Mierau GW, et al. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1989;13:439-458.
9. Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: A clinicopathologic review and conceptual discussion. Semin Diagn Pathol. 1995;12:233-248.
10. Yuri T, Danbara N, Shikata N, et al. Malignant rhabdoid tumor of the liver: case report and literature review. Pathol Int. 2004;54: 623-629.
11. Wagner LM, Garrett JK, Ballard ET, et al. Malignant rhabdoid tumor mimicking hepatoblastoma: A case report and literature review. Pediatr Dev Pathol. 2007;10:409-415.
12. Fanburg-Smith JC, Hengge M, Hengge UR, et al. Extrarenal rhabdoid tumors of soft tissue: A clinicopathologic and immunohistochemical study of 18 cases. Ann Diagn Pathol. 1998;2:351-362.
13. Foschini MP, Van Eyken P, Brock PR, et al. Malignant rhabdoid tumour of the liver. A case report. Histopathology. 1992;20:157-165.
14. Hunt SJ, Anderson WD. Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity. Am J Clin Pathol. 1990;94:645-648.
15. Kuroda H, Moritake H, Sawada K, et al. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. Cancer Genet Cytogenet. 2005;158:172-179.
16. Parham DM, Peiper SC, Robicheaux G, et al. Malignant rhabdoid tumor of the liver. Evidence for epithelial differentiation. Arch Pathol Lab Med. 1988;112:61-64.
17. Scheimberg I, Cullinane C, Kelsey A, et al. Primary hepatic malignant tumor with rhabdoid features. A histological, immunocytochemical, and electron microscopic study of four cases and a review of the literature. Am J Surg Pathol. 1996;20:1394-1400.
18. Fernandez C, Bouvier C, Sevenet N, et al. Congenital disseminated malignant rhabdoid tumor and cerebellar tumor mimicking medulloblastoma in monozygotic twins: pathologic and molecular diagnosis. Am J Surg Pathol. 2002;26:266-270.
19. White FV, Dehner LP, Belchis DA, et al. Congenital disseminated malignant rhabdoid tumor: A distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11. Am J Surg Pathol. 1999;23:249-256.
20. Fernandez C, Sevenet N, Bouvier-Labit C, et al. Atypical teratoid and rhabdoid tumor. Report of a congenital case. Ann Pathol. 2001;21:259-262.
21. Simons J, Teshima I, Zielenska M, et al. Analysis of chromosome 22q as an aid to the diagnosis of rhabdoid tumor: A case report. Am J Surg Pathol. 1999;23:982-988.
22. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004;28:1485-1491.
23. Rosty C, Peter M, Zucman J, et al. Cytogenetic and molecular analysis of a t (1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22. Genes Chromosomes Cancer. 1998;21:82-89.
24. Vujanic GM, Sandstedt B, Harms D, et al. Rhabdoid tumour of the kidney: A clinicopathological study of 22 patients from the International Society of Paediatric Oncology (SIOP) nephroblastoma file. Histopathology. 1996;28:333-340.
25. Rousseau-Merck MF, Versteege I, Legrand I, et al. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Cancer Res. 1999;59: 3152-3156.
26. Haberler C, Laggner U, Slavc I, et al. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol. 2006;30:1462-1468.
27. Judkins AR, Burger PC, Hamilton RL, et al. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol. 2005;64:391-397.
28. Saito T, Oda Y, Itakura E, et al. Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor. Pathol Int. 2001;51:532-542.
29. Bourdeaut F, Freneaux P, Thuille B, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol. 2007;211:323-330.
30. Caramel J, Medjkane S, Quignon F, et al. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Oncogene. 2008;27:2035-2044.
31. Kohashi K, Izumi T, Oda Y, et al. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: A useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum Pathol. 2009;40:349-355.
32. Kreiger PA, Judkins AR, Russo PA, et al. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Mod Pathol. 2009;22:142-150.
33. Russo P, Biegel JA. SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed? Pediatr Blood Cancer. 2009;52:312-313.
34. Savla J, Chen TT, Schneider NR, et al. Mutations of the hSNF5/ INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst. 2000;92:648-650.
35. Sigauke E, Rakheja D, Maddox DL, et al. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol. 2006;19:717-725.
36. Igarashi T, Sasano H, Konno R, et al. Malignant rhabdoid tumor of the vulva: case report with cytological, immunohistochemical, ultrastructural and DNA ploidy studies and a review of the literature. Pathol Int. 1998;48:887-891.
37. Kinoshita Y, Shiratsuchi H, Tamiya S, et al. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis. J Cancer Res Clin Oncol. 2001;127:351-358.
38. Kuroiwa K, Kinoshita Y, Shiratsuchi H, et al. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm. Histopathology. 2002;41:538-548.
39. Martinez-Lage JF, Ferri Niguez B, Sola J, et al. Rhabdoid meningioma: A new subtype of malignant meningioma also apt to occur in children. Childs Nerv Syst. 2006;22:325-329.
40. Nakamura I, Nakano K, Nakayama K, et al. Malignant rhabdoid tumor of the colon: report of a case. Surg Today. 1999;29: 1083-1087.
41. Oshiro Y, Shiratsuchi H, Oda Y, et al. Rhabdoid features in leiomyosarcoma of soft tissue: with special reference to aggressive behavior. Mod Pathol. 2000;13:1211-1218.
42. Oshiro Y, Shiratsuchi H, Tamiya S, et al. Extraskeletal myxoid chondrosarcoma with rhabdoid features, with special reference to its aggressive behavior. Int J Surg Pathol. 2000;8:145-152.
43. Machado I, Noguera R, Pellin A, et al. Molecular diagnosis of Ewing's sarcoma family of tumors A comparative analysis of 560 cases with FISH and RT-PCR. Diag Mol Pathol 2009. In press.
44. Noguera R, Machado I, Piqueras M, et al. Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines. Diagn Pathol. 2008;3:S27.
45. Piqueras M, Navarro S, Castel V, et al. Analysis of biological prognostic factors using tissue microarrays in neuroblastic tumors. Pediatr Blood Cancer. 2009;52:209-214.
46. Rousseau-Merck MF, Fiette L, Klochendler-Yeivin A, et al. Chromosome mechanisms and INI1 inactivation in human and mouse rhabdoid tumors. Cancer Genet Cytogenet. 2005;157: 127-133.
47. Gunduz K, Shields JA, Eagle RC Jr, et al. Malignant rhabdoid tumor of the orbit. Arch Ophthalmol. 1998;116:243-246.
48. Clairotte A, Ringenbach F, Laithier V, et al. Malignant rhabdoid tumor of the liver with spontaneous rupture: A case report. Ann Pathol. 2006;26:122-125.
49. Bouvier C, De Paula AM, Fernandez C, et al. Atypical teratoid/ rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy. Childs Nerv Syst. 2008; 24:143-147.
50. Ertan Y, Sezak M, Turhan T, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: clinicopathologic and immunohistochemical features of four cases. Childs Nerv Syst. 2009;25:707-711.
51. Ng TL, O'Sullivan MJ, Pallen CJ, et al. Ewing sarcoma with novel translocation t (2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn. 2007;9:459-463.
52. Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res. 2003;63:4568-4576.
53. Wang L, Bhargava R, Zheng T, et al. Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn. 2007;9:498-509.
54. Schofield DE, Beckwith JB, Sklar J. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15. 5 in renal rhabdoid tumors. Genes Chromosomes Cancer. 1996;15:10-17.
55. Albanese P, Belin MF, Delattre O. The tumour suppressor hSNF5/ INI1 controls the differentiation potential of malignant rhabdoid cells. Eur J Cancer. 2006;42:2326-2334.
56. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma. Am J Surg Pathol. 2009;33:542-550.